(Date:11/24/2009)...lable in Spanish . , The presence of increa...mmatory substances in the blood, hinders the loss ...arch project of the University of Navarra conducte...School of Pharmacy. , The project, entitled "A n...the control of body weight and inflammation," exam...
(Date:11/23/2009)... community-associated strain of the deadly superbu...ost common antibioticsposes a far greater health t...into hospitals, according to a study in the Decemb...he new threat is easily picked up in fitness cente...ased the overall burden of MRSA within hospitals, ...
(Date:11/23/2009)...3, 2009 - The time of day matters to forest trees ...duced by a research team led by Professor Malcolm ...-principal for research and colleagues in the depa...ge campus. , Capitalizing on their previous wo...search team examined how poplar trees use their 45...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference 14150 1Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference 14150 2Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference 14150 3Lower Drinking Age Linked to Later Life Problems 57675 1Lower Drinking Age Linked to Later Life Problems 57675 2Lower Drinking Age Linked to Later Life Problems 57675 3Cybernetwork to help K State researchers study tallgrass prairie respond to global warming 9982 1Cybernetwork to help K State researchers study tallgrass prairie respond to global warming 9982 2(Date:11/24/2009)...and,November24/PRNewswire-FirstCall/--deCODE,genet...ivednoticefrom,theNasdaqStockMarketthattradinginth...0,2009andaForm25-NSEwillbefiledwiththe,Securitiesa...stock,fromlistingonNasdaq,unlessthecompanyfilesana...panyhasfiledsuchanappeal,which,willstaythesuspensi...
(Date:11/24/2009)...and,November24/PRNewswire-FirstCall/--deCODE,genet...allofits,"firstday"motionsbytheU.S.BankruptcyCourt...CODElastweekfiledavoluntarypetitionfor,reliefunder...nkruptcyCourt. , TheordersissuedbytheBankrupt...essduringtheChapter11proceedings.Inparticular,the,...
(Date:11/24/2009)...4/PRNewswire-Asia/--ShanghaiBiolaxyannouncedthe,Ch...ovedthe,investigationalnewdrugapplication(IND)fori...ormulationtotreatdiabetes.ThisIND,approvalallowsBi... Diabetesisadisordercharacteristicofhighbloodgluco...enresultinseveremicro-and,macro-vasculardiseases,l...
(Date:11/24/2009)...yendpointhasbeenmetforpatientswithadvanced-stage,o....24/PRNewswire-FirstCall/-AEternaZentarisInc.(NASD...euticalcompanyfocusedonendocrinetherapyandoncology...ywithitstargetedcytotoxicpeptideconjugate,AEZS-108...endometrialcancer.Inapersonalizedhealthcareapproac...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4...oy, N.Y. Researchers at Rensselaer Polytechnic In...nexpensive, quick-drying polymer that could lead t...miconductor manufacturing and computer chip packag...nd cost savings for conventional photolithography ...siloxane (PES), should also enable a new generatio...
...E, Jan. 28 Cell Therapeutics, Inc.,(CTI) (Nasdaq ...g today,shareholders approved the proxy proposal a...corporation to increase the number of authorized,s...ase the number of,authorized shares of common stoc...co, Chief Financial Officer at CTI, who chaired th...
...ON, Jan. 28 /PRNewswire-FirstCall/ - Quest PharmaT...d that it has signed a,collaborative research agre...velop a combination therapy for the treatment of l...he Company,s lead oncology product,SL052, with var...that,photodynamic therapy (PDT) can augment the th...
Other Biology Technology:New polymer could improve semiconductor manufacturing, packaging 2Cell Therapeutics, Inc. (CTI) Shareholders Authorize Share Increase at Special Meeting of Shareholders 2Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer 2Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer 3Mouse Anti-Mouse Qa-2 Monoclonal Antibody, Alexa Fluor 647 Conjugated, Clone 695H1-9-9 from BioLegend
27-mer duplex from B-Bridge International
Propidium Iodide Buffer from BioLegend
Luminex 100 Instrument System from Upstate
Biology Products: